MyFinsight
Home
Blog
About
Contact
Download
Download image
Net gain
-$16,988K
(-65.98%↓ Y/Y)
Gain before
provision for income taxes
-$16,988K
(-65.98%↓ Y/Y)
Other income
(expense), net
$858K
(-62.94%↓ Y/Y)
Loss from operations
-$17,846K
(-42.20%↓ Y/Y)
Total operating
expenses
$17,846K
(40.74%↑ Y/Y)
Research and development
$11,181K
(67.91%↑ Y/Y)
General and
administrative
$6,665K
(10.70%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc. (OVID)